- Home
- STRS vs SGMO Comparison
STRS vs SGMO Comparison
Compare STRS & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRS
- SGMO
- Stock Information
- Founded
- STRS 1992
- SGMO 1995
- Country
- STRS United States
- SGMO United States
- Employees
- STRS N/A
- SGMO N/A
- Industry
- STRS Homebuilding
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STRS Real Estate
- SGMO Health Care
- Exchange
- STRS Nasdaq
- SGMO Nasdaq
- Market Cap
- STRS 218.2M
- SGMO 488.2M
- IPO Year
- STRS N/A
- SGMO 2000
- Fundamental
- Price
- STRS $18.80
- SGMO $1.03
- Analyst Decision
- STRS
- SGMO Buy
- Analyst Count
- STRS 0
- SGMO 5
- Target Price
- STRS N/A
- SGMO $5.20
- AVG Volume (30 Days)
- STRS 8.6K
- SGMO 11.4M
- Earning Date
- STRS 11-13-2024
- SGMO 11-12-2024
- Dividend Yield
- STRS N/A
- SGMO N/A
- EPS Growth
- STRS N/A
- SGMO N/A
- EPS
- STRS 0.19
- SGMO N/A
- Revenue
- STRS $48,157,000.00
- SGMO $52,291,000.00
- Revenue This Year
- STRS N/A
- SGMO N/A
- Revenue Next Year
- STRS N/A
- SGMO $5.97
- P/E Ratio
- STRS $96.90
- SGMO N/A
- Revenue Growth
- STRS 83.12
- SGMO N/A
- 52 Week Low
- STRS $18.28
- SGMO $0.30
- 52 Week High
- STRS $30.66
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- STRS 33.40
- SGMO 33.45
- Support Level
- STRS $19.20
- SGMO $0.91
- Resistance Level
- STRS $21.61
- SGMO $1.51
- Average True Range (ATR)
- STRS 0.91
- SGMO 0.20
- MACD
- STRS -0.09
- SGMO -0.11
- Stochastic Oscillator
- STRS 14.02
- SGMO 6.32
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.